Base5 Genomics
Palo Alto, US · Founded 2018 · Delaware corporation · 1 known investors
Founders & leadership
CC
Chihyu ChienNamed on SEC filing
SE
Solomon EndlichNamed on SEC filing
GS
Geoffrey SmithNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$5.3M disclosed across 2 rounds · 2020–2021
▶$4.2MraisedSep 2021 · 9 investors · OtherRule 506(b)
▶$4.2MraisedSep 2021 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan FriedlanderDirector
- Yuan Wei TaiDirector
- Solomon EndlichExecutive Officer, Director, Promoter
- Chihyu ChienDirector
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1MraisedJun 2020 · 5 investors · OtherRule 506(b)
▶$1MraisedJun 2020 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Chihyu ChienDirector
- Solomon EndlichExecutive Officer, Director, Promoter
- Geoffrey SmithDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Base5 Genomics's investors?
- Base5 Genomics's investors include Amed Ventures.
- How much funding has Base5 Genomics raised?
- Base5 Genomics has disclosed $5.3M raised across 2 rounds.
- Where is Base5 Genomics headquartered?
- Base5 Genomics is headquartered in Palo Alto, US.